Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 10/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.64 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | BIRC5 | O15392 | 1/20 | 0.43 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.43 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.43 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.43 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.43 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.43 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.43 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.43 |
| ▸ | EEF2K | O00418 | 1/20 | 0.42 |
| ▸ | PLK4 | O00444 | 1/20 | 0.42 |
| ▸ | IKBKB | O14920 | 1/20 | 0.42 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.42 |
| ▸ | PIM1 | P11309 | 1/20 | 0.42 |
| ▸ | CDK2 | P24941 | 1/20 | 0.42 |
| ▸ | AKT1 | P31749 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5162058 | 1.00 | CYP2C9 (0.64) | CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2 | |
| SCHEMBL5157472 | 0.86 | CYP2C9 (0.66) | CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2 | |
| SCHEMBL5157475 | 0.86 | CYP2C9 (0.66) | CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2 | |
| SCHEMBL5161837 | 0.84 | CYP2C9 (0.62) | CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2 | |
| SCHEMBL5159334 | 0.84 | CYP2C9 (0.67) | CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2 | |
| SCHEMBL5161844 | 0.84 | CYP2C9 (0.62) | CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2 | |
| SCHEMBL5159328 | 0.84 | CYP2C9 (0.67) | CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2 | |
| SCHEMBL6544425 | 0.83 | CYP2C9 (0.72) | CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2 | |
| SCHEMBL5159149 | 0.83 | CYP2C9 (0.66) | CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2 | |
| SCHEMBL5176260 | 0.83 | CYP2C9 (0.61) | CYP2C9CYP3A4CYP2C19CYP2D6CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1133474-B1 | 3-SUBSTITUTED-4-ARYLQUINOLIN-2-ONE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS | BRISTOL MYERS SQUIBB CO (US) | 2007-02-21 | — | — | EP | claimed |
| EP-1133474-A4 | 3-SUBSTITUTED-4-ARYLQUINOLIN-2-ONE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS | BRISTOL MYERS SQUIBB CO (US) | 2005-02-16 | — | — | EP | claimed |
| CN-1129582-C | 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators | BRISTOL MYERS SQUIBB CO (US) | 2003-12-03 | — | — | CN | claimed |
| CN-1329599-A | 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators | BRISTOL MYERS SQUIBB CO (US) | 2002-01-02 | — | — | CN | claimed |
| EP-1133474-A1 | 3-SUBSTITUTED-4-ARYLQUINOLIN-2-ONE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2001-09-19 | — | — | EP | claimed |
| US-6184231-B1 | NEUROPROTECTANTS; TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, TRAUMATIC BRAIN INJURY, SEXUAL DYSFUNCTION | BRISTOL-MYERS SQUIBB | 2001-02-06 | — | — | US | claimed |
| WO-2000034244-A1 | 3-SUBSTITUTED-4-ARYLQUINOLIN-2-ONE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2000-06-15 | — | — | WO | claimed |
| EP-1133474-B1 | 3-SUBSTITUTED-4-ARYLQUINOLIN-2-ONE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS | BRISTOL MYERS SQUIBB CO (US) | 2007-02-21 | — | — | EP | disclosed |
| EP-1133474-A4 | 3-SUBSTITUTED-4-ARYLQUINOLIN-2-ONE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS | BRISTOL MYERS SQUIBB CO (US) | 2005-02-16 | — | — | EP | disclosed |
| CN-1129582-C | 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators | BRISTOL MYERS SQUIBB CO (US) | 2003-12-03 | — | — | CN | disclosed |
| CN-1329599-A | 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators | BRISTOL MYERS SQUIBB CO (US) | 2002-01-02 | — | — | CN | disclosed |
| EP-1133474-A1 | 3-SUBSTITUTED-4-ARYLQUINOLIN-2-ONE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2001-09-19 | — | — | EP | disclosed |
| US-6184231-B1 | NEUROPROTECTANTS; TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, TRAUMATIC BRAIN INJURY, SEXUAL DYSFUNCTION | BRISTOL-MYERS SQUIBB | 2001-02-06 | — | — | US | disclosed |
| WO-2000034244-A1 | 3-SUBSTITUTED-4-ARYLQUINOLIN-2-ONE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2000-06-15 | — | — | WO | disclosed |